Clinical trial
STI571 in Treating Patients With Recurrent Leukemia
NCT00004932 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00004932 |
|---|---|
| Title | STI571 in Treating Patients With Recurrent Leukemia |
| Official title | A Phase I Study of STI571 in Ph+ Leukemia |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | imatinib mesylate |
| Enrollment | 31 |
| Start date | Jan 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 21, 2014 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: